TY  - GEN
AU  - Négrier,Sylvie
AU  - Perol,David
AU  - Ravaud,Alain
AU  - Bay,Jacques O
AU  - Oudard,Stéphane
AU  - Chabaud,Sylvie
AU  - Fargeot,Pierre
AU  - Delva,Remy
AU  - Deplanque,Gael
AU  - Gravis,Gwenaelle
AU  - Escudier,Bernard
TI  - Randomized study of intravenous versus subcutaneous interleukin-2, and IFNalpha in patients with good prognosis metastatic renal cancer
SN  - 1078-0432
PY  - 2008///1008
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Injections, Intravenous
KW  - Injections, Subcutaneous
KW  - Interferon-alpha
KW  - administration & dosage
KW  - Interleukin-2
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Prognosis
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-08-0236
ER  -